Apotex Seeks Restitution For FDA Import Alert Before World Bank’s Arbitration Arm
This article was originally published in The Pink Sheet Daily
Executive Summary
Apotex claims an FDA import alert on two of its facilities caused damages in excess of $520 million; its complaint alleging U.S. government violation of NAFTA is the second it has brought before the International Centre for Settlement of Investment Disputes.